Permeability classification of representative fluoroquinolones by a cell culture method

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Biopharmaceutics
• Drug Discovery and Development

Background:

• The Biopharmaceutic Classification System (BCS) provides a framework for drug substance categorization.
• Understanding drug permeability is crucial for predicting in vivo absorption and bioavailability.
• Fluoroquinolones represent a class of antibiotics with variable absorption characteristics.

Purpose of the Study:

• To categorize the permeability of representative fluoroquinolone drugs (ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin).
• To assess the efflux potential of these fluoroquinolones using an in vitro Caco-2 assay.
• To evaluate the applicability of an in vitro permeability method for BCS classification.

Main Methods:

• Utilized an in vitro Caco-2 cell permeability assay with established method suitability.
• Measured permeability of four fluoroquinolones and compared them to known standards (metoprolol, atenolol, labetalol, rhodamine-123).
• Determined permeability class and efflux potential based on concentration-dependent transport and absorptive vs. secretive transport ratios.

Main Results:

• All tested fluoroquinolones exhibited concentration-dependent permeability, suggesting active transport.
• Fluoroquinolones showed varying degrees of efflux: ciprofloxacin > lomefloxacin > rhodamine 123 > levofloxacin > ofloxacin.
• Ciprofloxacin was classified as low permeability, while lomefloxacin, levofloxacin, and ofloxacin were classified as high permeability, consistent with in vivo bioavailability data.

Conclusions:

• The in vitro Caco-2 permeability assay effectively classifies fluoroquinolone drugs according to BCS guidelines.
• In vitro permeability data correlate well with human in vivo absolute bioavailability, validating the method.
• This study demonstrates the utility of in vitro assays for predicting drug behavior and aiding drug development.